Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Addex Therapeutics (ADXN) Return on Assets (2020 - 2025)

Addex Therapeutics' Return on Assets history spans 6 years, with the latest figure at 0.0% for Q4 2025.

  • On a quarterly basis, Return on Assets fell 1.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 1.0% decrease, with the full-year FY2025 number at 0.0%, down 2.0% from a year prior.
  • Return on Assets came in at 0.0% for Q4 2025, down from 0.0% in the prior quarter.
  • The five-year high for Return on Assets was 0.01% in Q1 2025, with the low at 0.04% in Q1 2024.
  • Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.0% in 2021.
  • Biggest five-year swings in Return on Assets: decreased -3bps in 2024 and later rose 5bps in 2025.
  • Year by year, Return on Assets stood at 0.01% in 2021, then tumbled by -42bps to 0.01% in 2022, then tumbled by -141bps to 0.03% in 2023, then skyrocketed by 139bps to 0.01% in 2024, then crashed by -117bps to 0.0% in 2025.
  • Business Quant data shows Return on Assets for ADXN at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.